We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
(-8.6%)
Cap. Flow
-$9.95B
Cap. Flow
% of AUM
-14.55%
Top 10 Holdings %
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$433M |
| 2 |
Merck
MRK
|
+$286M |
| 3 |
Jacobs Solutions
J
|
+$265M |
| 4 |
Equifax
EFX
|
+$253M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$710M |
| 2 |
Johnson & Johnson
JNJ
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
| 4 |
Marvell Technology
MRVL
|
+$377M |
| 5 |
Wells Fargo
WFC
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 12% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Weibo
WB
$1.95B
| $10K | ﹤0.01% |
1,085
+688
| +173% | +$6.59K |
|
1927
WEC Energy
WEC
$35.3B
| $10K | ﹤0.01% |
107
-27,590
| -100% | -$2.68M |
|
1928
Ferrovial N.V. Ordinary Shares
FER
$48B
| $10K | ﹤0.01% |
247
-22
| -8% | -$895 |
|
1929
GDS Holdings
GDS
$6.55B
| $9K | ﹤0.01% |
419
+116
| +38% | +$2.45K |
|
1930
The Mosaic Company
MOS
$7.44B
| $9K | ﹤0.01% |
378
-50
| -12% | -$1.31K |
|
1931
Sabesp
SBS
$19.1B
| $8K | ﹤0.01% |
3,135
-1,423
| -31% | -$4.34K |
|
|
NBIS
1932
Nebius Group N.V.
NBIS
$55.6B
| $8K | ﹤0.01% |
313
-14,011
| -98% | -$342K |
|
1933
DocGo
DCGO
$62M
| $7K | ﹤0.01% |
1,713
-239,355
| -99% | -$922K |
|
1934
Dole
DOLE
$1.31B
| $7K | ﹤0.01% |
537
-232,039
| -100% | -$3.56M |
|
1935
Fresenius Medical Care
FMS
$12.8B
| $7K | ﹤0.01% |
336
-82
| -20% | -$1.78K |
|
1936
Innovative Industrial Properties
IIPR
$1.7B
| $7K | ﹤0.01% |
106
-306
| -74% | -$34.4K |
|
1937
Oxford Industries
OXM
$580M
| $7K | ﹤0.01% |
96
-11,066
| -99% | -$868K |
|
1938
Puma Biotechnology
PBYI
$407M
| $7K | ﹤0.01% |
2,495
+2,005
| +409% | +$5.83K |
|
1939
Pro-Dex
PDEX
$212M
| $7K | ﹤0.01% |
+152
| New | +$6.19K |
|
1940
Taylor Devices
TAYD
$170M
| $7K | ﹤0.01% |
174
-30
| -15% | -$1.36K |
|
|
PSTX
1941
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $7K | ﹤0.01% |
797
+669
| +523% | +$3.49K |
|
|
AGEN
1942
Agenus
AGEN
$324M
| $6K | ﹤0.01% |
+2,464
| New | +$9.12K |
|
1943
CenterPoint Energy
CNP
$26.8B
| $6K | ﹤0.01% |
202
-89
| -31% | -$2.74K |
|
1944
Frequency Electronics
FEIM
$778M
| $6K | ﹤0.01% |
360
+278
| +339% | +$3.91K |
|
1945
Flotek Industries
FTK
$1.3B
| $6K | ﹤0.01% |
709
+414
| +140% | +$2.82K |
|
1946
Jabil
JBL
$35.5B
| $6K | ﹤0.01% |
+44
| New | +$5.77K |
|
|
MOMO
1947
Hello Group
MOMO
$855M
| $6K | ﹤0.01% |
+851
| New | +$6.04K |
|
1948
Atara Biotherapeutics
ATRA
$76.9M
| $5K | ﹤0.01% |
444
+315
| +244% | +$3.32K |
|
1949
CytomX Therapeutics
CTMX
$729M
| $5K | ﹤0.01% |
5,505
-3,323
| -38% | -$3.58K |
|
1950
electroCore
ECOR
$58.9M
| $5K | ﹤0.01% |
+354
| New | +$4.09K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.
- Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
- Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
- Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
- Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
- Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
- Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
- Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.
Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.